Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
27.21
-0.43 (-1.56%)
At close: Dec 5, 2025, 4:00 PM EST
27.46
+0.25 (0.92%)
After-hours: Dec 5, 2025, 7:54 PM EST
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $2.14 billion as of December 5, 2025. Its market cap has increased by 328.68% in one year.
Market Cap
2.14B
Enterprise Value
1.82B
1-Year Change
328.68%
Ranking
Category
Stock Price
$27.21
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has increased from $1.79B to $2.14B, an increase of 19.27%. That is a compound annual growth rate of 3.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 2.14B | 397.69% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | 1.84B | 2.54% |
| Nov 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |